DSIP 10mg (10 vials/kit): Delta Sleep-Inducing Neuropeptide for Circadian & Stress Research
In physiological and electroencephalographic (EEG) research, DSIP is recognized for its unique ability to induce slow-wave (delta) sleep patterns without causing sedative central nervous system depression or disrupting REM sleep architecture. Beyond sleep modulation, DSIP acts as an endocrine regulator within the central nervous system. It normalizes basal levels of adrenocorticotropic hormone ($\text{ACTH}$) and plasma cortisol under acute physiological stress, modulates luteinizing hormone ($\text{LH}$) secretion, and suppresses free radical formation, making it a critical tool for neuroprotection and stress adaptation models.
Maintaining consistent peptide integrity and preventing hydrolytic cleavage is essential for quantitative behavioral and physiological bioassays. The DSIP 10mg (10 vials/kit) configuration supplies a total yield of 100mg active material distributed across ten individual 10mg USP Type I borosilicate glass vials. Lyophilized under sterile vacuum conditions, each vial contains a highly stable, uniform powder cake. This multi-vial kit structure allows researchers to reconstitute only the working stock required for immediate experimental runs, keeping remaining kit stock preserved in sub-zero stasis and eliminating structural loss caused by repeated freeze-thaw cycles.
Neuroendocrine Pathways, Sleep Architecture, and Technical Profile of DSIP
The primary scientific value of DSIP 10mg (10 vials/kit) stems from its multi-target regulatory activity within the central nervous and endocrine systems:
-
Delta-Wave EEG Synchronization: Promotes slow-wave delta EEG rhythm activity and restores natural sleep-wake architecture in preclinical sleep disorder models.
-
HPA Axis & Cortisol Normalization: Modulates hypothalamic release of Corticotropin-Releasing Hormone ($\text{CRH}$), preventing excessive stress-induced spikes in $\text{ACTH}$ and glucocorticoid levels.
-
Pituitary Hormone Regulation: Interacts with hypothalamic signaling to stimulate basal $\text{LH}$ release and modulate somatostatin activity without impairing baseline physiological secretion.
-
Antioxidant & Cytoprotective Defense: Inhibits lipid peroxidation and quenches intracellular reactive oxygen species ($\text{ROS}$), protecting neuronal tissue against hypoxia and ischemic stress.
-
Ultra-High Chemical Purity ($\ge$99.0%): Manufactured via automated Solid-Phase Peptide Synthesis ($\text{SPPS}$) and purified using preparative High-Performance Liquid Chromatography ($\text{HPLC}$) to guarantee absolute structural fidelity.
| Biochemical / Technical Parameter | Technical Profile for DSIP 10mg (10 vials/kit) |
| Product Identifier | DSIP 10mg (10 vials/kit) / Delta Sleep-Inducing Peptide |
| Chemical Sequence | $\text{H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH}$ |
| CAS Registry Number | 62568-57-4 |
| Molecular Formula | $\text{C}_{35}\text{H}_{48}\text{N}_{10}\text{O}_{15}$ |
| Molecular Mass | Approximately 848.81 g/mol |
| Chemical Purity | $\ge$99.0% (Verified by analytical HPLC peak integration) |
| Physical Appearance | White to off-white, sterile lyophilized powder cake |
| Package Configuration | 10 USP Type I Borosilicate Glass Vials per Kit (10mg per vial) |
| Primary Research Domains | Circadian rhythm modulation, HPA axis stress adaptation, EEG bioassays, neuroprotection |
Reconstitution Guidelines, Laboratory Storage Standards, and Quality Protocols
Achieving reproducible, publication-grade results when working with DSIP 10mg (10 vials/kit) requires strict adherence to standardized laboratory preparation and climate-controlled storage protocols.
Perform all reconstitution procedures inside a certified Class II Biosafety Cabinet:
-
Temperature Equilibration: Allow the frozen DSIP 10mg (10 vials/kit) vial to adjust to ambient room temperature prior to solvent introduction to eliminate internal moisture condensation.
-
Septum Sanitization: Remove the protective plastic flip-cap and thoroughly wipe the synthetic rubber stopper with a fresh 70% isopropyl alcohol swab. Allow the surface to dry completely.
-
Slow Diluent Addition: Using a sterile syringe equipped with a fine-gauge needle, draw the required volume of Bacteriostatic Water (0.9% benzyl alcohol), Sterile Normal Saline (0.9% NaCl), or Sterile Water for Injection. Direct the liquid stream against the inner glass wall so it trickles slowly over the lyophilized cake.
-
Gentle Hydration: Allow the diluent to fully hydrate the powder cake for 2 minutes. Gently roll the vial between your palms or swirl in smooth circular motions until clear. Never vortex or shake vigorously, as high-shear agitation can shear peptide bonds and induce protein foaming.
-
Micro-Aliquot Strategy: For multi-week testing protocols, divide reconstituted liquid into sterile, single-use microcentrifuge tubes under aseptic conditions to prevent atmospheric oxidation and eliminate repeated freeze-thaw cycles.
| Operational Storage Phase | Recommended Environmental Conditions | Bioactive Stability Duration |
| Unopened Lyophilized Kit | Deep Freeze at -20°C to -80°C (Protected from light and moisture) | 24 to 36 Months |
| Unopened Short-Term Storage | Refrigerated at 2°C to 8°C (Sealed dark storage container) | Up to 90 Days |
| Reconstituted Solution | Refrigerated at 2°C to 8°C (In Bacteriostatic Water or Saline) | Up to 21–28 Days |
| Frozen Liquid Aliquots | Deep Freeze at -20°C or colder (Single freeze-thaw max) | Up to 6 Months |
Batch Quality Documentation & Traceability: Every production lot of DSIP 10mg (10 vials/kit) undergoes third-party analytical testing. High-Performance Liquid Chromatography (HPLC) chromatograms confirm component purity exceeding 99.0%, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms precise theoretical molecular mass. Each shipment includes a batch-specific Certificate of Analysis (COA) documenting chemical purity, residual solvent analysis, heavy metal screens, and bacterial endotoxin levels (<0.05 EU/mg) to satisfy institutional compliance requirements.
Strict Regulatory & Research Compliance Statement: DSIP 10mg (10 vials/kit) is produced, packaged, and distributed exclusively for in vitro laboratory research, academic experimentation, chemical synthesis, and preclinical research. DSIP 10mg (10 vials/kit) is strictly not intended, formulated, or approved for human or animal consumption, therapeutic medical treatment, clinical diagnostic work, or cosmetic applications. All handling must be conducted by certified research personnel operating within equipped laboratory facilities in compliance with OSHA workplace safety regulations and institutional biosafety protocols.





Reviews
There are no reviews yet.